Markets › United States › NAS › NEUP

Neuphoria Therapeutics Inc

NAS:NEUPHealthcarenasdaq_composite

$3.31+0.30%At closeAt close · Tue 20 Oct · ≈ AED 12.16 · Market cap $17.91M · Next earnings Wed 2 Dec

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	−136.7%	−2,604.4%	—	—	95.8%	43.5%	—	—
Operating margin	−965.7%	−8,095.2%	—	—	−7.2%	−1,401.1%	−7.2%	+1393.9 pts
Net margin	−704.5%	−5,986.9%	—	—	−2.4%	−1,145.7%	−2.4%	+1143.3 pts
EBITDA margin	−486.8%	−7,895.4%	—	—	−0.8%	−1,344.6%	—	—
Return on equity	−18.3%	−40.3%	−219.7%	−88.6%	−1.3%	−54.7%	−1.3%	+53.4 pts
Return on assets	−16.0%	−35.1%	−165.9%	−56.0%	−0.9%	−46.9%	−0.9%	+46.0 pts
Return on capital employed	−23.0%	−50.1%	−216.7%	−112.5%	−3.0%	−58.9%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+461.9%
Debt / assets	1.6%	1.1%	3.0%	1.0%	0.5%	0.1%	—	—
Interest coverage	−8.3×	−1,154.4×	−1,118.0×	0.0×	0.0×	0.0×	—	—
Current ratio	13.1×	12.5×	2.2×	3.4×	3.6×	27.8×	3.6×	−87.2%
Quick ratio	13.1×	12.5×	2.2×	3.4×	3.6×	27.8×	—	—
Cash ratio	12.1×	10.0×	2.0×	3.3×	3.4×	26.3×	3.4×	−87.2%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.4×	0.0×	—	—
Receivables turnover	4.8×	0.1×	0.0×	0.0×	1,309.8×	1.4×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—